Kashiv BioSciences

Piscataway, United States

Kashiv BioSciences is a biopharmaceutical company that develops and manufactures biosimilars and complex peptide-based medicines.

$72.3M raised

Dec 2025

Debt Financing

Biotechnology Life Science Pharmaceutical

Top Investors

GoldenTree Asset Management Union Bank of India Tarsadia Investments

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Kashiv BioSciences

How much funding has Kashiv BioSciences raised?

Kashiv BioSciences has raised $72.3M in total funding. The most recent round was Debt Financing. The last funding was announced in December 2025.

Who are Kashiv BioSciences's investors?

Kashiv BioSciences's investors include GoldenTree Asset Management, Union Bank of India, Tarsadia Investments.

Where is Kashiv BioSciences headquartered?

Kashiv BioSciences is headquartered in Piscataway, United States.

What does Kashiv BioSciences do?

Kashiv BioSciences is a biopharmaceutical company that develops and manufactures biosimilars and complex peptide-based medicines.

What stage is Kashiv BioSciences at?

Kashiv BioSciences is at the Debt Financing stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated December 22, 2025.

MLA

"Kashiv BioSciences — Funding & Investors." VCBacked, December 22, 2025, https://www.vcbacked.co/company/kashiv-biosciences. Accessed July 3, 2026.

APA

VCBacked. (2025). Kashiv BioSciences — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/kashiv-biosciences

Wikipedia (cite web)

{{cite web |title=Kashiv BioSciences — Funding & Investors |url=https://www.vcbacked.co/company/kashiv-biosciences |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated December 22, 2025.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Allterum Therapeutics

Houston$1.0M

AlpalifeBio

Woburn$9.8M

Renaissance BioScience

Vancouver$599K

Epsilogen

London$16.3M

Advanced Microbiome Interventions

Amsterdam$300K